Add BrightSurf on Google Email

A novel probe technology for detecting native albumin activity as a biomarker in patients with hepatitis B-related cirrhosis and hepatocellular carcinoma and its clinical applications

A novel ratiometric fluorescent probe was synthesized to detect native human albumin (HA) activity in patients with hepatitis B cirrhosis and hepatocellular carcinoma. Native HA activity levels were significantly higher in low albumin groups, correlating with increased severity of liver disease.

SourceXia & He Publishing Inc.·JournalFuture Integrative Medicine·DateOct 29, 2024

Development and validation of a new prognostic model for predicting survival outcomes in patients with acute-on-chronic liver failure

A new prognostic model accurately predicts short-term mortality in ACLF patients, offering improved clinical decision-making. The Model for end-stage liver disease-complication score demonstrated superior predictive accuracy and robustness in external cohorts.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateOct 27, 2024

Identification and validation of the Hsa_circ_0001726/miR-140-3p/KRAS axis in hepatocellular carcinoma based on microarray analyses and experiments

This study identifies the hsa_circ_0001726/miR-140-3p/KRAS axis as a key regulator in hepatocellular carcinoma (HCC) progression and lenvatinib resistance. The axis is involved in promoting cell proliferation and migration, and is also linked to overall survival in HCC patients.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateOct 27, 2024

Advanced liver fibrosis predicts liver outcomes in biopsy-proven metabolic dysfunction-associated steatotic liver disease

A U.S.-based single-center retrospective cohort study found that advanced liver fibrosis is a primary risk factor for incident liver decompensation and liver-related events in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease. The study, published in the Journal of Clinical and Translational Hepatolog...

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateOct 25, 2024

Transcriptomic landscape analysis reveals a persistent DNA damage response in metabolic dysfunction-associated steatohepatitis post-dietary intervention

Metabolic dysfunction-associated steatohepatitis (MASLD) exhibits persistent activation of the DNA damage response (DDR) and its primary transcription factor P53 even after dietary reversal. Elevated P53 levels correlate with hepatocyte ballooning, suggesting a link between DDR signaling and MASLD recurrence.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateOct 24, 2024

Study shows changes to organ allocation policy reduced waiting time and increased transplants for children with pediatric acute liver failure

A recent study by Children's Hospital Los Angeles showed that reprioritizing organ allocation led to better outcomes for children with PALF. The changes resulted in substantially decreased deaths on the pediatric waitlist, increased rates of liver transplant, and improved post-transplant outcomes.

SourceChildren's Hospital Los Angeles·JournalJAMA Surgery·TypeObservational study·DateOct 2, 2024

Effects of transjugular intrahepatic portosystemic shunt on renal and pulmonary function in hepatic decompensation with and without hepatorenal and hepatopulmonary syndromes

The TIPS procedure improves renal function in patients with portal hypertension, particularly those with refractory ascites. However, the benefits of TIPS for Hepatorenal Syndrome (HRS) and Hepatopulmonary Syndrome (HPS) are limited due to insufficient data.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 25, 2024

Korea University offers new breakthrough for Hepatitis C to improve life expectancy

A new study by Korea University College of Medicine shows that direct-acting antivirals significantly reduce liver-related clinical outcomes and lower the risk of disease progression to cancer or cirrhosis, increasing life expectancy for patients with Hepatitis C. The treatment approach has a high effectiveness rate of 90%.

SourceKorea University College of Medicine·JournalEClinicalMedicine·TypeData/statistical analysis·DateAug 20, 2024

Controlling lipid levels with less side effects possible with new drug

Scientists have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone receptor beta (THRβ) to treat lipid disorders. Mice administered the drug showed decreased lipid levels in the liver and blood with fewer side effects compared to existing compounds.

SourceInstitute of Transformative Bio-Molecules (ITbM), Nagoya University·JournalCommunications Medicine·TypeExperimental study·DateAug 6, 2024

Cell atlas of regenerating liver

Scientists analyzed 21,000 cells from tissue samples to develop a cell atlas of regenerating liver tissue. The study reveals changes in cell composition, gene expression, and intercellular communication that facilitate liver regeneration after portal vein embolization.

SourceUniversität Leipzig·JournalNature Communications·TypeExperimental study·DateJul 30, 2024

Liver transplant outperforms other therapies for colorectal cancer that has spread to the liver

A study published in JAMA Surgery shows that liver transplants significantly improve progression-free survival rates for patients with unresectable colorectal liver metastases compared to other therapies. At three years, 90% of transplant patients remained cancer-progression free, whereas only 42% of those receiving alternative treatme...

SourceUniversity of Rochester Medical Center·JournalJAMA Surgery·TypeObservational study·DateJul 30, 2024

Preventing cancer cells from colonizing the liver

Cancer cells can attach themselves to liver cells when specific proteins are present, allowing them to colonize and form new tumors. This discovery provides insights into the metastatic process and may lead to potential treatments that prevent cancer from establishing new tumors.

SourceETH Zurich·JournalNature·TypeExperimental study·DateJul 24, 2024

Chinese expert consensus on refined diagnosis, treatment and management of advanced primary liver cancer: 2023 edition

Experts have established a comprehensive guideline for classifying and treating advanced liver cancer in China. The guidelines recommend personalized treatment options based on tumor characteristics, vascular tumor thrombus grade, distant metastasis, liver function status, portal hypertension, and hepatitis B virus replication status.

SourceKeAi Communications Co., Ltd.·JournalLiver Research·TypeSurvey·DateJul 17, 2024

Paleolithic diets are not without risks

A recent UNIGE study highlights the risks of high-protein diets, also known as Paleolithic diets, which can lead to severe neurological disorders. Excess protein increases ammonium production, overwhelming the liver and potentially causing coma in severe cases.

SourceUniversité de Genève·JournalJournal of Biological Chemistry·TypeNews article·DateJul 17, 2024

Heritable chronic cholestatic liver diseases

These disorders, including CHF, CD, CS, ALGS, and BA, result from genetic mutations affecting bile formation and transport. Management focuses on symptom control, prevention of complications, and definitive treatment with liver transplantation when indicated.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJul 17, 2024

Etiologies of splenic venous hypertension

Splenic venous hypertension is a rare condition characterized by upper GI bleeding without liver disease. It arises due to increased pressure in the splenic vein, leading to gastric varices. Diagnosis involves clinical suspicion, imaging studies, and endoscopic methods.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJul 16, 2024

Timing is everything: Study finds link between bowel movement frequency and overall health

Researchers found that bowel movement frequency is linked to long-term health, with younger people, women, and those with lower BMI tending to have less frequent bowel movements. The study also showed associations between bowel movement frequency and chronic disease risk, mental health history, and gut microbiome composition.

SourceInstitute for Systems Biology·JournalCell Reports Medicine·DateJul 16, 2024

Progress in the management of patients with cholestatic liver disease: where are we and where are we going?

Significant progress has been made in understanding and managing cholestatic liver diseases, with emerging therapies like OCA, fibrates, and budesonide. Multidisciplinary approaches involving hepatologists, gastroenterologists, and primary care physicians are crucial for improving patient outcomes.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJul 12, 2024

Cirrhosis affects twice as many transgender adults as cisgender adults

A new study from Keck Medicine of USC reveals a startling disparity in the frequency of liver disease among transgender individuals, with double the prevalence of cirrhosis compared to cisgender adults. The study highlights the need for more supportive, preventive care and emphasizes the importance of early prevention.

SourceUniversity of Southern California - Health Sciences·JournalThe American Journal of Gastroenterology·DateJul 10, 2024

Hepatitis C leaves “scars” in immune cells even after successful treatment

Researchers found that the frequency of activated TREG cells remained elevated during treatment and continued to be high even after the virus was eliminated. Inflammatory features, such as increased TNF signaling, were sustained in TREG cells, indicating long-term immune system changes induced by the chronic infection.

SourceInstitute for Basic Science·JournalJournal of Hepatology·TypeExperimental study·DateJul 9, 2024

Subnormal serum liver enzyme levels

Subnormal serum liver enzyme levels can result from deficiencies in pyridoxal 5'-phosphate (vitamin B6), as well as conditions such as chronic kidney disease. Recognizing these patterns is crucial for early diagnosis and management of diseases, allowing for targeted treatments and improved patient outcomes.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJul 2, 2024